Kliniske studier for Lupus i Maryland
10 studier for Lupus søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50730, Rockville
RekruttererFase 3
Alder 16 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06617325Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda
RekruttererObservasjonsstudie
Alder 18 til 120 · Kvinner · Oppdatert 28. sep. 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Silver Spring
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07430306Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05440422Study of Systemic Lupus Erythematosus
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 3 til 120 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT00001372A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Baltimore
RekruttererFase 1/2
Alder 18 til 70 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
RekruttererFase 1
Alder 18 til 74 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Arthritis & Rheumatism Associates, Rockville
RekruttererObservasjonsstudie
Alder 16 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07175285Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 18 til 120 · Kvinner · Oppdatert 31. jul. 2026 · NCT06032923Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.